[ARWR] QoQ Quarter Result on 30-Sep-2024 [#Q4]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
26-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q4]
Profit Trend
QoQ- 0.15%
YoY- -55.49%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 0 0 0 3,551 16,097 15,825 146,267 -
PBT -172,798 -173,977 -126,996 -138,689 -108,990 -103,383 47,676 -
Tax 546 0 -1,696 -3,313 2,025 742 -999 -
NP -170,536 -170,793 -125,300 -132,864 -109,679 -102,946 48,675 -
Tax Rate - - - - - - 2.10% -
Total Cost 170,536 170,793 125,300 136,415 125,776 118,771 97,592 44.93%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 0.00 0.00 0.00 -3,741.59 -681.36 -650.53 33.28 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS 0.00 -1.38 -1.02 -1.24 -1.02 -0.96 0.46 -
EPS Diluted 0.00 -1.38 -1.02 -1.24 -1.02 -0.96 0.45 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.